Small molecule immune oncology

Focusing on a novel immune-oncology target that is highly pursued by global pharmaceutical companies, we aim to maintain the lead position in pharmacology research and drug development. At the same time, we are expanding the indication into infectious diseases (antiviral) and strive to become the leading innovator in this field.